The Objective of this Innovation: A single pipeline of immunotherapy that can help all cancer patients, despite tumor type and genetic background.

Cancer is listed as the top ten cause of death in Taiwan, amongst which lung cancer ranks first in the top ten cancers for both genders. In order to effectively treat and control cancer...

Doctor Jan-Gowth Chang from The Center for Precision in China Medical University Hospital (CMUH) pointed out that “precision medicine” uses genetic sequencing technology to provide precise diagnosis and treatment based on genetic difference and to avoid delays in treatment and side effects.

The complicated process of opening and taking out the cells from the traditional cryovials has caused inconvenience to medical personnel and increased the risk of contamination when treating patients. With the pursuit of perfection and strict requirements for product specifications, UnicoCell Biomed has developed and designed a cell storage cryogenic container suitable for clinical use.

According to data from the World Health Organization (WHO) survey, 27% of adults worldwide suffer from sleep problems of varying degrees.

Avision Inc. has been devoted to the medical device since 2012, and came across a rare opportunity by working together with U.S.-based company Capsovision Inc. to develop exciting new technologies and becoming the sole distributor of that product in Taiwan, and officially being released to the market.

Taipei Veterans General Hospital has launched the Center to advance in precision medicine

The new plant will be situated in the Special Economic Zone in East Java JIIPE, Indonesia, focusing on biologics.

AI-DR is the world's first AI-powered software that identifies DR by types, stages and lesions- all at the same time.  

TCI acquires a manufacturing facility from US-based NewAge and strikes a long-term deal with the company for manufacturing and global expansion

VeriSee has been approved by Thailand and Indonesia's FDA, with aims at market expansion in Asia

P1101, a new drug developed by PharmaEssentia, which targets the rare disease myeloproliferative neoplasms (MPNs), is now featuring on BBC StoryWorks

A domestic production of one type of rapid coronavirus test kits for use at home has been approved by Taiwan FDA

The nasal swab test provides results within 24 hours after samples arrive at Amazon's labs

Those who test positive asked to get second test at designated screening center

A drug candidate developed by Golden Biotechnology Corp. of COVID-19 will be administered to seriously ill patients in its Phase II clinical trials in the United States, awaiting authorisation by the relevant authorities.

The service provides remote care via video conferencing or telephone, targets outpatients with chronic diseases or people in need of outpatient services. (Photo courtesy of Taipei Medical University Hospital)

The partnership will enable global genomic sequencing and examination through a specialist platform developed on Oracle Cloud Infrastructure to help mitigate the impact of potentially dangerous COVID-19 variants.

Booth selection rescheduled on 15 June for exhibitors with 6+ booths and 30 July for others.